Clinical Trial Update: Study of 68Ga-R10602 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for 68Ga-R10602 in hormone receptor-positive breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 68Ga-R10602

Snippet

Sponsor: Radionetics Oncology | Conditions: Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer | Phase 1 | Status: RECRUITING